Kemnay Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Kemnay Advisory Services's VRTX Position: Q2 2026 in Review
Kemnay Advisory Services increased its Vertex Pharmaceuticals (VRTX) stake by 4.9% in Q2 2026, buying an estimated $2.22K and bringing the position to 107 shares worth $53.1K. The position accounts for 0.01% of the portfolio, ranked #274.
Kemnay Advisory Services first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Kemnay Advisory Services held 107 shares of Vertex Pharmaceuticals worth $53.1K as of Q2 2026.
- Kemnay Advisory Services bought 5 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.22K.
- Vertex Pharmaceuticals made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #274 holding.
- Kemnay Advisory Services first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.